Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
ID: 335040Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/335040

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-255.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated research in computational genomics and data science through the R21 grant mechanism, specifically excluding clinical trials. This grant aims to enhance fundamental genomics research by supporting innovative analytical methodologies and tools that are applicable to human health and disease, with a focus on scalable management of complex genomic datasets. The funding is particularly important for advancing computational approaches, data integration, visualization, and secure data sharing, which are critical for the biomedical research community. Eligible applicants include a wide range of entities such as academic institutions, nonprofits, and government organizations, with project budgets capped at $275,000 over two years. Interested parties should contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance and must submit their applications by January 7, 2025.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-21-255-Full-Announcement.html
    PAR-21-255.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the National Human Genome Research Institute (NHGRI), is offering a funding opportunity for investigator-initiated research in computational genomics and data science (R21 Clinical Trial Not Allowed). This reissue of PAR-21-255 aims to enhance fundamental genomics research through innovative analytical methodologies and tools applicable to human health and disease, specifically focusing on the scalable and effective management of complex genomic datasets. Eligible applicants include academic institutions, nonprofits, for-profit organizations, and government entities with project budgets capped at $275,000 over two years. Research proposals should prioritize advancements in computational approaches, data integration, visualization, and secure data sharing, while also considering issues related to human subjects, diversity, and reproducibility. The NIH encourages new and diverse investigators, urging early contacts with NHGRI program staff to ensure alignment with the grant's objectives. The ultimate goal is to support the development of robust, user-friendly tools and methodologies that facilitate genomic data analysis and interpretation across various biological systems, thereby contributing significantly to the biomedical research community.
    Similar Opportunities
    Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for "Investigator Initiated Research in Computational Genomics and Data Science" (R01 Clinical Trial Not Allowed) aimed at advancing research in computational genomics, data science, and bioinformatics with applications to human health and disease. This initiative encourages innovative research efforts that enhance analytical methodologies, develop software tools, and improve genomic data management, with a focus on creating scalable solutions for increasingly large datasets. Eligible applicants include a diverse range of organizations such as higher education institutions, non-profits, and for-profit entities, with no cost-sharing requirement and a maximum budget of $500,000 in direct costs for projects not exceeding five years. Interested applicants should submit their proposals by January 7, 2025, and can direct inquiries to grantsinfo@nih.gov for further assistance.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Exploratory/Developmental Research Grant to develop novel theories and methodologies for understanding the genetic architecture of complex human traits. The objective is to support innovative research that explores both genetic and non-genetic factors influencing trait variation across biological, social, and ecological levels, with a particular emphasis on addressing cancer disparities and employing systems epidemiology modeling. This grant allows for a budget of up to $275,000 over a two-year period, and applications are open to a diverse range of organizations, including higher education institutions and nonprofits. Interested applicants can find more information and submit their proposals by the close date of January 7, 2027, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) to support innovative biomedical and clinical research projects. This grant aims to foster exploratory research that may involve significant risks but has the potential for breakthroughs or the development of novel methodologies in health-related fields. The program is crucial for advancing research that addresses pressing health challenges and encourages applications that present new scientific ideas distinct from traditional R01 projects. Eligible applicants include a wide range of institutions, including higher education institutions, nonprofits, and for-profit organizations, both domestic and foreign, with a budget limit of $275,000 over two years and a maximum request of $200,000 in any single year. Interested parties should submit their applications electronically by January 7, 2025, and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further assistance.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) to support innovative research projects at the preliminary or conceptual stage, particularly those with the potential to advance biomedical, behavioral, or clinical research. Applicants must include at least one clinical trial in their proposals, focusing on mechanistic studies that align with the scientific missions of participating NIH Institutes and Centers. This funding opportunity is crucial for stimulating novel research that challenges conventional methods and improves clinical practices, with a maximum budget of $275,000 available for a two-year project, and no more than $200,000 allocated in any single year. Interested applicants should adhere to strict submission guidelines and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance; the application deadline is January 7, 2025.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), has announced a funding opportunity for Small Research Grants (R03) aimed at analyzing existing genomic data related to dental, oral, and craniofacial health. This initiative encourages projects that utilize publicly available genomic data and advanced methodologies, focusing on oral health disparities and biological pathways to identify intervention targets. The grant supports projects with budgets up to $200,000 over two years, with applications due by May 7, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.